Distinct clinical, neuroimaging and genetic profiles of late-onset cobalamin C defects (cb1C): a report of 16 Chinese cases
暂无分享,去创建一个
[1] M. Irving,et al. Best practice guidelines for management of spinal disorders in skeletal dysplasia , 2020, Orphanet Journal of Rare Diseases.
[2] M. Baumgartner,et al. Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry , 2018, Journal of Inherited Metabolic Disease.
[3] W. Craigen,et al. Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. , 2017, Molecular genetics and metabolism.
[4] M. Baumgartner,et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.
[5] G. Diaz,et al. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. , 2015, Molecular genetics and metabolism.
[6] R. Banerjee,et al. Pathogenic Mutations Differentially Affect the Catalytic Activities of the Human B12-processing Chaperone CblC and Increase Futile Redox Cycling* , 2015, The Journal of Biological Chemistry.
[7] J. Lupski,et al. Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull’s Eye Maculopathy , 2015, Ophthalmic genetics.
[8] M. Baumgartner,et al. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy , 2014, Orphanet Journal of Rare Diseases.
[9] Eda Özaydın,et al. Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene , 2014, European Journal of Pediatrics.
[10] M. Baumgartner,et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect , 2014, Journal of Inherited Metabolic Disease.
[11] T. Naidich,et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. , 2013, Molecular genetics and metabolism.
[12] J. Jia,et al. A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China , 2012, Journal of the Neurological Sciences.
[13] R. Chandler,et al. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management , 2012, Journal of Inherited Metabolic Disease.
[14] C. Venditti,et al. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes , 2012, Journal of Inherited Metabolic Disease.
[15] Xuefan Gu,et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China , 2010, Journal of Inherited Metabolic Disease.
[16] E. Richard,et al. Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC) , 2009, Human mutation.
[17] M. Baumgartner,et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.
[18] A. Radmanesh,et al. Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature , 2008, Pediatric Radiology.
[19] G. Uziel,et al. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.
[20] F. Sedel,et al. Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: A diagnostic approach , 2007, Journal of Inherited Metabolic Disease.
[21] S. Blaser,et al. Late‐onset cobalamin‐C disorder: A challenging diagnosis , 2007, American journal of medical genetics. Part A.
[22] C. Morel,et al. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.
[23] M. Seashore,et al. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) , 1997, Journal of Inherited Metabolic Disease.
[24] E. Shoubridge,et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.